Hikma Pharmaceuticals USA INC.
2
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-05-06 to 2026-09-02
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-09-02 | FDA Drug | FDA Recall: Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (ND | Hikma Pharmaceuticals USA INC. | Class II | N/A |
| 2026-05-06 | FDA Drug | FDA Recall: Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. | Hikma Pharmaceuticals USA INC | Class II | N/A |